How much funding has RegenX Biosciences raised?

RegenX Biosciences has raised $108.4M in total funding, most recently a Series D round.

When was RegenX Biosciences founded?

RegenX Biosciences was founded in 2008.

Where is RegenX Biosciences headquartered?

RegenX Biosciences is headquartered in Rockville, Maryland, United States.

What industry is RegenX Biosciences in?

RegenX Biosciences operates in Biotech, Healthcare.

How many employees does RegenX Biosciences have?

RegenX Biosciences has 201-500 employees.

RegenX Biosciences

IPO

Improving lives through the curative potential of gene therapy

Rockville, United States · Founded 2008 · $108.4M raised

Biotech

Healthcare

Headquarters: Rockville, Maryland
Employees: 201–500
Founded: 2008
Business Model: B2B

Total Funding: $108.4M
Last Round: $70.5M Series DMay 2015
Rounds: 3

About

REGENXBIO is a leading clinical-stage biotechnology company developing gene therapy treatments using its proprietary NAV® Technology Platform, which encompasses over 100 novel AAV vectors. The company focuses on rare and retinal diseases including wet AMD, Duchenne muscular dystrophy, and MPS II, aiming to deliver one-time curative treatments to patients.

Summary

RegenX Biosciences is a Biotech company based in Rockville, United States, founded in 2008. It has raised $108.4M in total across 3 rounds, most recently a $70.5M Series D round in May 2015.

LinkedIn X (Twitter)